Cargando…
Listeria monocytogenes infection associated with alemtuzumab – - a case for better preventive strategies
BACKGROUND: The mortality of septicaemia, meningitis and encephalitis caused by Listeria monocytogenes is 20–40%. Twenty-one cases of invasive listeriosis associated with alemtuzumab, including at least 16 in patients with multiple sclerosis, have been published or reported to the World Health Organ...
Autores principales: | Holmøy, Trygve, von der Lippe, Hedda, Leegaard, Truls Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381036/ https://www.ncbi.nlm.nih.gov/pubmed/28376817 http://dx.doi.org/10.1186/s12883-017-0848-8 |
Ejemplares similares
-
Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
por: Myro, Aija Zuleron, et al.
Publicado: (2018) -
A Case of Listeria monocytogenes Infective Endocarditis
por: Badar, Faraz, et al.
Publicado: (2022) -
Uncommon manifestations of Listeria monocytogenes infection
por: Chavada, Ruchir, et al.
Publicado: (2014) -
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
por: Holmøy, Trygve, et al.
Publicado: (2019) -
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases
por: Rau, Daniela, et al.
Publicado: (2015)